Evidence map›Paper›PMID 31500188›Full record

ArticleInternational journal of molecular sciences2019

Downregulation of POFUT1 Impairs Secondary Myogenic Fusion Through a Reduced NFATc2/IL-4 Signaling Pathway.

Audrey Der Vartanian, Julien Chabanais, Claire Carrion, Abderrahman Maftah, Agnès Germot

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. All-International journal of molecular sciences · 2023
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Audrey Der VartanianPEIRENE, EA 7500, Glycosylation et différenciation cellulaire, Université de Limoges, F-87000 Limoges, France.
Julien ChabanaisPEIRENE, EA 7500, Glycosylation et différenciation cellulaire, Université de Limoges, F-87000 Limoges, France.ORCID 0000-0003-3114-1677
Claire CarrionUMR CNRS 7276, Contrôle de la Réponse Immune et des Lymphoproliférations, Université de Limoges, F-87000 Limoges, France.
Abderrahman MaftahPEIRENE, EA 7500, Glycosylation et différenciation cellulaire, Université de Limoges, F-87000 Limoges, France.ORCID 0000-0002-0196-435X
Agnès GermotPEIRENE, EA 7500, Glycosylation et différenciation cellulaire, Université de Limoges, F-87000 Limoges, France. agnes.germot@unilim.fr.ORCID 0000-0002-9010-9178
Université de Limoges · FRCentre National de la Recherche Scientifique · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Past work has shown that the protein

Indexed as

Gene Expression RegulationSignal TransductionAnimalsCell DifferentiationCell LineFucosyltransferasesGene Knockdown TechniquesInterleukin-4MiceMuscle DevelopmentMuscle Fibers, SkeletalNFATC Transcription FactorsReceptors, NotchFucosyltransferasesInterleukin-4Nfatc2 protein, mouseNFATC Transcription FactorsPofut1 protein, mouseReceptors, NotchIL-4myogenic differentiationNFATc2NOTCH pathwayPOFUT1secondary fusion

Identifiers

PMID31500188
PMCPMC6770550
OpenAlexW2971706132

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.